PharmSight Strengthens Global Footprint with New Office in Zug (Switzerland); Launches Conversity’s AI Training Platform
New European hub set to transform negotiation training, sales force performance, and market access with advanced AI
PharmSight Research & Analytics today announces the opening of its European hub in Zug, Switzerland. Operating as PharmSight GmbH, this strategic expansion reinforces the company’s commitment to deliver data-driven insights for negotiation training, sales force optimization, and market access solutions in the heart of Europe’s pharmaceutical ecosystem.
Leading PharmSight GmbH is Mr Gianclaudio Floria, recently appointed CEO with over 20 years of experience in commercial operations and strategic roles at industry giants like Amgen, BMS, Fresenius Kabi, Gilead, and Alexion. A published author and recognized thought leader, Mr. Floria brings extensive international expertise in Finance, M&A, Strategic Planning, and Market Access, reinforcing PharmSight’s vision for Europe.
A cornerstone of the Zug launch is the debut of Conversity, an AI-driven training platform that leverages ultra-realistic avatars, scenario-based simulations, and real-time analytics to elevate negotiation and sales performance. Conversity helps professionals navigate complex agreements, optimize market access, and refine sales engagement. With this addition to its European portfolio, PharmSight further cements its role as a trusted partner in the region’s pharmaceutical landscape.
“Our Zug office marks a significant step in our global journey,” said Siddharth Pathela, Co-founder of PharmSight. “We’re excited to unveil Conversity, the latest addition to our proprietary AI toolkit – Intellisight, Pharmlens, Pharmalert, and Cintel. Conversity is set to transform negotiation and sales training, delivering strong value to the biopharma sector.”
This milestone follows PharmSight’s recent launch in the U.S. market. With offices in Boston and now Zug, PharmSight is planning expansion into the Middle East and establishing an innovation center focused on AI/ML.
About PharmSight
PharmSight is a global consulting firm serving the biopharmaceutical industry through advanced data management and analytics, forecasting, CI, HEOR, reporting automation, patient analytics, and AI-driven solutions. Headquartered in Gurugram, India, with offices in Boston and Zug, PharmSight’s 50+ consultants collaborate with clients worldwide to transform data into actionable insights.
About Conversity
Conversity is an AI-powered negotiation training platform designed specifically for the pharmaceutical sector. With its immersive simulations, customized scenarios, and in-depth analytics, Conversity equips professionals to master negotiation skills, enhance market access, and achieve superior sales performance.
For more information, please visit www.pharmsight.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250616604727/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Dreamstime Launches “Zero Gravity” Unlimited Downloads Plan17.6.2025 14:21:00 CEST | Press release
Dreamstime, the world’s largest stock photography community, announced the launch of its new Zero Gravity Plan,an Unlimited Downloads subscription that promises an exciting array of high-quality images. This plan is designed to meet creatives' needs for a value-and-variety model while providing contributors with fair performance-based rewards. Key Takeaways:Unlimited Downloads: Unrestricted access to tens of millions of high-quality images for a flat fee. Rotating Content: Downloads are replaced by fresh content to ensure diversity and uniqueness. Performance Rewards: Payouts based on actual download performance from a dedicated monthly Contributor Royalty Pool. Sustainable Model: Balances unlimited user access with long-term and new contributor value. As the name suggests, the Zero Gravity Planis limitless, subject to reasonable usage,giving subscribers unlimited access to an expansive collection of tens of millions of high-quality images, including landscapes, portraits, abstract art
Celltrio Secures $15 Million Financial Investment to Accelerate Global Expansion in Cell Culturing and Cell & Gene Therapy Automation17.6.2025 14:07:00 CEST | Press release
Celltrio®, a pioneering life sciences company delivering advanced automation solutions for cell culturing and cell & gene therapy, today announced the closing of a $15 million financial investment round led by Premier Partners, a leading investor in healthcare innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610129377/en/ The new funding will accelerate the global commercialization of RoboCell®, Celltrio’s flagship modular platform for fully automated, sterile cell culturing and cell therapy manufacturing. Investment proceeds will be used to scale manufacturing capabilities, expand commercial operations across North America, Europe, and Asia and fuel continued innovation of GMP-ready automation solutions for biopharma, regenerative medicine, and advanced research laboratories. “This investment marks a major milestone for Celltrio and validates our mission to streamline, scale, and standardize cell manufacturing
DDC Enterprise Announces Up to $528 Million Raise to Accelerate Bitcoin Treasury Strategy17.6.2025 14:00:00 CEST | Press release
Landmark Funding Dedicated Exclusively to Bitcoin Acquisition Positions DDC to Become a Global Leader in Bitcoin Holdings DDC Enterprise Limited (NYSE: DDC) (“DDC” or the “Company”) today announced it has entered into three securities purchase agreements for a total of up to $528 million of gross proceeds to the Company, before placement agent fees and offering expenses. Investors include Anson Funds, Animoca Brands, Kenetic Capital, QCP Capital, and a network of leading institutional funds and individual Bitcoin investors. Substantially all of the capital raise will be dedicated to expanding the Company’s Bitcoin treasury. This transformative financing, among the largest single-purpose Bitcoin raises by any NYSE-listed company, is expected to accelerate DDC's mission to establish one of the most valuable corporate Bitcoin holdings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250616739727/en/ This transformative financing
NTT DATA Research Reveals C-Suite Misalignment Over GenAI Adoption17.6.2025 14:00:00 CEST | Press release
Nearly half of CISOs have negative sentiments about GenAI rollouts, despite CEO optimism CEOs are all-in on GenAI, but CISOs warn that security gaps and aging infrastructure are holding back progress Alignment requires stronger governance and dedicated investment NTT DATA, a global leader in digital business and technology services, today launched its new report, “The AI Security Balancing Act: From Risk to Innovation,” highlighting the opportunities and risks AI presents in cybersecurity. The findings show a misalignment among C-Suite leaders when it comes to business goals and operational readiness for GenAI deployment. The report, which includes data from an NTT DATA survey of more than 2,300 senior GenAI decision makers,comprising 1,500 *C-Suite leaders across 34 countries, found that while CEOs and business leaders are committed to GenAI adoption, CISOs and operational leaders lack the necessary guidance, clarity and resources to fully address security risks and infrastructure cha
ASISA Partners with HCLTech to Drive Digital Transformation and Expansion in Iberia17.6.2025 13:41:00 CEST | Press release
HCLTech, a leading global technology company, has been selected by ASISA, a prominent health insurance provider in Spain, as its strategic IT partner to accelerate business transformation and expansion in Iberia. This partnership aims to accelerate ASISA's digital transformation journey to enhance the experience for its 2.2 million customers and position the company at the forefront of innovation in the region. HCLTech will modernize ASISA's IT platforms and leverage AI-based solutions to enhance business efficiency. The comprehensive mainframe modernization and solutions from HCLTech will enable ASISA to create a more agile, responsive IT infrastructure. “Partnering with HCLTech marks a key step in our digital transformation journey. By modernizing our platforms and embracing cutting-edge technologies, we are reinforcing our commitment to delivering exceptional service to our customers,” said José Pereira, CTO at ASISA. “This collaboration will empower ASISA with a more agile, scalabl
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom